Daejeon, South Korea

Bon-Kyoung Koo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Korea Advanced Institute of Science and Technology. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bon-Kyoung Koo. Retrieved from https://idiyas.com/inventor/bon-kyoung-koo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bon-Kyoung Koo: Innovator in Transgenic Research

Introduction

Bon-Kyoung Koo is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of transgenic research, particularly in understanding the mechanisms regulating cell proliferation and differentiation during the development stage of mammalian embryos. His work has implications for cancer research and therapeutic development.

Latest Patents

Koo holds a patent titled "Transgenic mouse defective in WW45 function and use in screening compounds for anti-tumour activity." This patent presents differentiation regulators, methods of regulating differentiation, and transgenic organisms with a loss of expression of the differentiation regulator. The patent also outlines methods for preparing these transgenic organisms, showcasing Koo's innovative approach to addressing complex biological challenges.

Career Highlights

Koo is affiliated with the Korea Advanced Institute of Science and Technology, where he has been instrumental in advancing research in his field. His work has garnered attention for its potential applications in screening compounds for anti-tumor activity, contributing to the broader understanding of cancer biology.

Collaborations

Some of Koo's notable coworkers include Joo-Hyeon Lee and Tae-Shin Kim. Their collaborative efforts have further enriched the research environment and fostered innovation in transgenic studies.

Conclusion

Bon-Kyoung Koo's contributions to transgenic research exemplify the impact of innovative thinking in the scientific community. His work not only advances our understanding of cellular mechanisms but also paves the way for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…